@article{9d5c9e90f6a148c1a1c2acf8ceb6de90,
title = "Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences",
abstract = "Pleuropulmonary blastoma is a rare childhood malignancy of lung mesenchymal cells that can remain dormant as epithelial cysts or progress to high-grade sarcoma. Predisposing germline loss-of-function DICER1 variants have been described. We sought to uncover additional contributors through whole exome sequencing of 15 tumor/normal pairs, followed by targeted resequencing, miRNA analysis and immunohistochemical analysis of additional tumors. In addition to frequent biallelic loss of TP53 and mutations of NRAS or BRAF in some cases, each case had compound disruption of DICER1: a germline (12 cases) or somatic (3 cases) loss-of-function variant plus a somatic missense mutation in the RNase IIIb domain. 5p-Derived microRNA (miRNA) transcripts retained abnormal precursor miRNA loop sequences normally removed by DICER1. This work both defines a genetic interaction landscape with DICER1 mutation and provides evidence for alteration in miRNA transcripts as a consequence of DICER1 disruption in cancer. ",
author = "Pugh, {T. J.} and W. Yu and J. Yang and Field, {A. L.} and L. Ambrogio and Carter, {S. L.} and K. Cibulskis and P. Giannikopoulos and A. Kiezun and J. Kim and A. McKenna and E. Nickerson and G. Getz and S. Hoffher and Messinger, {Y. H.} and Dehner, {L. P.} and Roberts, {C. W.M.} and C. Rodriguez-Galindo and Williams, {G. M.} and Rossi, {C. T.} and M. Meyerson and Hill, {D. A.}",
note = "Funding Information: Sequence data used for this analysis are available from dbGaP under accession phs000543. The work was conducted as part of the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Health Institute in Mexico. We would like to acknowledge the technical expertise and data generation efforts of The Broad Institute Genomics Platform and Cancer Genome Analysis group. TJP was supported by a Canadian Institutes of Health Research Fellowship. DAH is supported by National Cancer Institute (R01CA143167), and National Heart, Lung and Blood Institute (R01HL109265 and R01HL111190). We thank the members of the Ogawa Laboratory for shared insights during reporting of genomic findings of PPB.34",
year = "2014",
month = nov,
day = "6",
doi = "10.1038/onc.2014.150",
language = "English",
volume = "33",
pages = "5295--5302",
journal = "Oncogene",
issn = "0950-9232",
number = "45",
}